Insulin Pen Extractor With Needle-Cap Fluid Coupling

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Individuals with Type 2 diabetes face the risk of wasting residual insulin in used insulin pens due to the inability to access and reuse the remaining medication, leading to unnecessary costs and waste.

Innovation Solution

An extractor system comprising a syringe, a first cap with a hypodermic needle, and a second cap that fluidically connects to the syringe, allowing extraction of residual insulin from insulin pens by piercing the pen's seal and transferring the medication into the syringe.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If insulin pens are designed with sealed closures to maintain medication integrity, then reliability is improved, but the ability to access residual medication is lost

Engineering Contradiction:
Improvemedication integrityVSAvoidaccess to residual medication
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The device is divided into separate functional components: a first cap for attaching to the syringe, a second cap for attaching to the insulin pen, and a hypodermic needle connecting them. This segmentation allows the needle to pierce the sealed closure and create a fluid pathway without compromising the overall integrity of the system.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The hypodermic needle acts as an intermediary element that bridges the sealed insulin pen and the syringe. It pierces the closure to establish fluid communication while the caps serve as intermediary coupling mechanisms that connect the needle to both devices without direct contact between the syringe and pen.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of manufacture

If insulin is sold in fixed packaging units, then manufacturing and distribution are simplified, but waste increases when residual insulin cannot be reused

Engineering Contradiction:
Improvepackaging standardizationVSAvoidresidual insulin waste
Core Design Contradiction:
Ease of manufactureVSLoss of substance

Solution Approach 1:

The device enables recovery of residual insulin that would otherwise be discarded. By providing a mechanism to extract remaining medication from used pens, it transforms what would be waste into reusable medication, directly addressing the loss of substance problem while maintaining compatibility with standard insulin pen packaging.

Inventive Principle:
Principle #34Discarding and recovering

3Ease of operation

If a simple extraction device is used, then ease of operation is improved, but fluidic connection reliability may be compromised

Engineering Contradiction:
Improveextraction simplicityVSAvoidfluidic connection
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The first cap and second cap are nested together with the hypodermic needle extending through both. The needle passes through the closed end of the second cap and protrudes into its internal cavity, creating a nested structure that ensures proper alignment and secure fluidic connection while maintaining a compact, easy-to-operate design.

Inventive Principle:
Principle #7Nested doll (Nesting)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables the recovery of residual insulin, reducing waste and costs associated with insulin use by allowing reuse of the remaining medication.

Implementation Method 1

The hypodermic needle extends through the closed end of the second cap and protrudes into an internal cavity of the second cap such that an internal cavity of the first cap fluidically communicates with the internal cavity of the second cap through an internal lumen of the hypodermic needle

Methodology Applied
Scientific EffectFluid flow through lumen:

Data Source

PatentUS20250312239A1Extractors and methods of using
Publication Date: 2025.10.09 PIERSON ANTIONE
  • US20250312239A1 patent drawing
  • US20250312239A1 patent drawing
  • US20250312239A1 patent drawing

AI summary

Extractors and methods of extracting a medication from another medical device, such as an insulin pen. The extractor includes a syringe, a first cap having an open end adapted to be coupled to the syringe, a hypodermic needle protruding from a closed end of the first cap, and a second cap coupled at a closed end thereof to the first cap by the hypodermic needle, which extends through the closed end of the second cap and protrudes into an internal cavity of the second cap such that an internal cavity of the first cap fluidically communicates with the internal cavity of the second cap through the hypodermic needle. An open end of the second cap can be coupled to the medical device so that the internal cavity of the second cap fluidically communicates with the medical device through the hypodermic needle.